Literature DB >> 19373982

Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them.

Lisa H Conti1, Jane E Sutherland, Carey M Muhlhauser.   

Abstract

Levels of prepulse inhibition (PPI) depend on the interval between the startling and prepulse stimuli. Brown Norway rats show less PPI of the acoustic startle response than Wistar-Kyoto (WKY) rats when the interval between the prepulse and startling stimulus is 100 ms. Central administration of corticotropin-releasing factor (CRF) decreases PPI at this inter-stimulus interval. Here, the effect of CRF on PPI over a range of inter-stimulus intervals was examined in WKY and BN rats, and in the F1 generation of a cross between them. Rats received an intracerebroventricular infusion of either saline or CRF 30 min prior to testing PPI. Test trials included startle stimulus alone trials, and trials on which a prepulse stimulus of either 6, 12, or 15 dB above background preceded the startling stimulus by either 20, 75, 100, 500 or 2000 ms. CRF decreased PPI in WKY rats at all inter-stimulus intervals and all prepulse intensities, while the effect of CRF on PPI in BN rats only occurred at intermediate intervals. BN and WKY rats showed different levels of PPI only at the intermediate intervals. Baseline PPI in the F1 rats resembled the WKY phenotype. The CRF-induced change in PPI in the F1 generation has some qualities of the effects in each of the progenitor strains. These results suggest that both the effect of rats strain and of CRF on PPI depend on the inter-stimulus interval, and that there is an interaction between prepulse stimulus intensity and the inter-stimulus interval.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373982      PMCID: PMC2768553          DOI: 10.1016/j.bbr.2009.01.008

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  66 in total

Review 1.  CRF and CRF receptors: role in stress responsivity and other behaviors.

Authors:  Tracy L Bale; Wylie W Vale
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

2.  No prepulse inhibition deficits in patients with unipolar depression.

Authors:  Stephan Ludewig; Katja Ludewig
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

Review 3.  Mouse genetic models for prepulse inhibition: an early review.

Authors:  M A Geyer; K L McIlwain; R Paylor
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

4.  Identification of quantitative trait loci for prepulse inhibition in rats.

Authors:  Abraham A Palmer; Laura L Breen; Pamela Flodman; Lisa H Conti; M Anne Spence; Morton P Printz
Journal:  Psychopharmacology (Berl)       Date:  2002-11-09       Impact factor: 4.530

5.  Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs.

Authors:  Anneloes Dirks; Lucianne Groenink; Koen G C Westphal; Jocelien D A Olivier; P Monika Verdouw; Jan van der Gugten; Mark A Geyer; Berend Olivier
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

6.  Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects.

Authors:  Frederic J Sautter; Garth Bissette; Justin Wiley; Gina Manguno-Mire; Benjamin Schoenbachler; Leann Myers; Janet E Johnson; Arleen Cerbone; Dolores Malaspina
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

7.  Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia.

Authors:  Katja Ludewig; Mark A Geyer; Franz X Vollenweider
Journal:  Biol Psychiatry       Date:  2003-07-15       Impact factor: 13.382

8.  Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients.

Authors:  Torben Mackeprang; Klaus T Kristiansen; Birte Y Glenthoj
Journal:  Biol Psychiatry       Date:  2002-11-01       Impact factor: 13.382

9.  Prepulse facilitation and prepulse inhibition in schizophrenia patients and their unaffected siblings.

Authors:  Jonathan K Wynn; Michael E Dawson; Anne M Schell; Mark McGee; Dustin Salveson; Michael F Green
Journal:  Biol Psychiatry       Date:  2004-03-01       Impact factor: 13.382

10.  Genetic influences on prepulse inhibition of startle reflex in humans.

Authors:  Andrey P Anokhin; Andrew C Heath; Erin Myers; Angela Ralano; Suzanne Wood
Journal:  Neurosci Lett       Date:  2003-12-15       Impact factor: 3.046

View more
  5 in total

1.  Restraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptor.

Authors:  Jane E Sutherland; Lisa H Conti
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

2.  Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats.

Authors:  Wei-li Chang; Neal R Swerdlow; Michelle R Breier; Niveditha Thangaraj; Martin Weber
Journal:  Pharmacol Biochem Behav       Date:  2010-04-10       Impact factor: 3.533

3.  Corticotropin-releasing factor and noradrenergic signalling exert reciprocal control over startle reactivity.

Authors:  Jodi E Gresack; Victoria B Risbrough
Journal:  Int J Neuropsychopharmacol       Date:  2010-12-21       Impact factor: 5.176

4.  Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating.

Authors:  Elizabeth Flandreau; Victoria Risbrough; Ailing Lu; Martin Ableitner; Mark A Geyer; Florian Holsboer; Jan M Deussing
Journal:  Psychoneuroendocrinology       Date:  2014-12-11       Impact factor: 4.905

5.  Kalrn plays key roles within and outside of the nervous system.

Authors:  Prashant Mandela; Maya Yankova; Lisa H Conti; Xin-Ming Ma; James Grady; Betty A Eipper; Richard E Mains
Journal:  BMC Neurosci       Date:  2012-11-01       Impact factor: 3.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.